Trader’s Round Up: EnteroMedics Inc. (ETRM), Lamb Weston Holdings, Inc. (LW), Bill Barrett Corporation (BBG)

EnteroMedics Inc. (ETRM) grew with the stock adding 2.55% or $0.19 to close at $7.64 on light trading volume of 1.39M compared its three months average trading volume of 11.98M. The St. Paul Minnesota 55113 based company operating under the Medical Appliances & Equipment industry has been trending up for the last 52 weeks, with the shares price now 564.35% up for the period and up by 282% so far this year. With price target of $140 and a 19000% rebound from 52-week low, EnteroMedics Inc. has plenty of upside potential, making it a hold with a view buy.

EnteroMedics Inc., a medical device company, focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders. Its proprietary neuroblocking technology is designed to intermittently block the vagus nerve using electrical impulses. The company develops the Maestro Rechargeable System, which is used to limit the expansion of the stomach, control hunger sensations between meals, reduce the frequency and intensity of stomach contractions, and produce a feeling of early and prolonged fullness. It has collaboration with Mayo Clinic for the development and testing of products for the treatment of obesity. The company was formerly known as Beta Medical, Inc. and changed its name to EnteroMedics Inc. in 2003. EnteroMedics Inc. was founded in 2002 and is headquartered in St. Paul, Minnesota.

Lamb Weston Holdings, Inc. (LW) dropped $-0.02 to close the day at a new closing price of $39.63, a -0.05% decrease in value from its previous closing price that moved the stock 34.48% above its 52 week low of $29.62. A total of 1.39M shares exchanged hands during the day compared with its three month average trading volume of 1.95M. The stock, which fluctuated between $39.2 and $39.75 during the day, currently situated -0.43% below its 52 week high. The stock is up by 7.98% in the past one month and down by 0% over the past three months. With a one year target estimate of $40.5 and RSI of 73.81, the stock still has upside potential, making it a sell for now.

Lamb Weston Holdings, Inc. produces and markets value-added frozen potato products worldwide. It operates through four segments: Global, Foodservice, Retail, and Other. The company offers frozen potatoes, sweet potatoes, and appetizers under the Lamb Weston brand name, as well as various customer labels. It serves retail and foodservice customers; grocery, mass, club, and specialty retailers; and businesses, independent restaurants, regional chain restaurants, and convenience stores, as well as primary, secondary, and post-secondary educational institutions. The company was founded in 1950 and is based in Eagle, Idaho.

Bill Barrett Corporation (BBG) shares were up in last trading by 0.17% to $5.97. It experienced lighter than average volume on day. The stock increased in value by almost 1.7% over the past week and fell -17.77% in the past month. It is currently trading -14.66% below its 50 day moving average and -8.18% below its 200 day moving average. Following the recent increase in price, the stock’s new closing price represents a -36.35% decrease in value from its one year high of $9.38. The RSI indicator value of 36.86, lead us to believe that it is a hold for now.

Bill Barrett Corporation, an independent energy company, acquires, explores for, and develops oil and natural gas resources in the United States. It primarily holds interests in the Denver-Julesburg basin and the Uinta oil program in the Uinta Basin in the Rocky Mountain region of the United States. The company was founded in 2002 and is headquartered in Denver, Colorado.

 

Stocks Highlights: Owens Corning (OC), Axion Power International, Inc. (AXPW), EnteroMedics Inc. (ETRM)

Owens Corning (OC) had a active trading with around 1.15M shares changing hands compared to its three month average trading volume of 1.09M. The stock traded between $57.31 and $58 before closing at the price of $57.51 with 0.56% change on the day. The Toledo Ohio 43659 based company is currently trading 45.96% above its 52 week low of $39.98 and -1.3% below its 52 week high of $58.69. Both the RSI indicator and target price of 66.38 and $56.2 respectively, lead us to believe that it should be put on hold over the coming weeks.

Owens Corning, together with its subsidiaries, produces and sells glass fiber reinforcements and other materials for composites; and residential and commercial building materials worldwide. It operates in three segments: Composites, Insulation, and Roofing. The Composites segment manufactures, fabricates, and sells glass reinforcements in the form of fiber; and manufactures and sells glass fiber products in the form of fabrics, non-wovens, and other specialized products. Its products are used in pipe, roofing shingles, sporting goods, consumer electronics, telecommunications cables, boats, aviation, defense, automotive, industrial containers, and wind-energy applications in the building and construction, transportation, consumer, industrial, and power and energy markets. The Insulation segment manufactures and sells fiberglass insulation into residential, commercial, industrial, and other markets for thermal and acoustical applications; and manufactures and sells glass fiber pipe insulation, flexible duct media, bonded and granulated mineral fiber insulation, and foam insulation used in above- and below-grade construction applications. This segment sells its products primarily to the insulation installers, home centers, lumberyards, retailers, and distributors. The Roofing segment manufactures and sells residential roofing shingles, oxidized asphalt materials, and roofing components used in residential and commercial construction, and specialty applications, as well as synthetic packaging materials. This segment sells its products through home centers, lumberyards, retailers, distributors, and contractors, as well as to roofing contractors for built-up roofing asphalt systems and to manufacturers in automotive, chemical, rubber, and construction industries. Owens Corning was founded in 1938 and is headquartered in Toledo, Ohio.

Axion Power International, Inc. (AXPW) managed to rebound with the stock declining 0% or $0 to close the day at $0.01 on light trading volume of 1.14M shares, compared to its three month average trading volume of 392.01K. The New Castle Pennsylvania 16105 based company has been underperforming the industrial electrical equipment group over the past 52 weeks, with the stock losing 0%, compared to the industry which has advanced 45.62% over the same period. With RSI of 0, the stock should still continue to rise and get closer to its one year target estimate of $0, making it a hold for now.

Axion Power International, Inc., an energy solutions company, develops carbon/lead batteries. The company sells batteries, energy storage systems, and engineering services. Its PbC (lead carbon) batteries and battery components are used in energy system storage functions. The company was founded in 2003 and is based in New Castle, Pennsylvania.

EnteroMedics Inc. (ETRM) shares were down in last trading by -2.04% to $7.69. It experienced lighter than average volume on day. The stock increased in value by almost 0.65% over the past week and fell -45.07% in the past month. It is currently trading 51.97% above its 50 day moving average and 423.18% above its 200 day moving average. Following the recent decrease in price, the stock’s new closing price represents a -74.71% decrease in value from its one year high of $30.41. The RSI indicator value of 51.99, lead us to believe that it is a hold for now.

EnteroMedics Inc., a medical device company, focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders. Its proprietary neuroblocking technology is designed to intermittently block the vagus nerve using electrical impulses. The company develops the Maestro Rechargeable System, which is used to limit the expansion of the stomach, control hunger sensations between meals, reduce the frequency and intensity of stomach contractions, and produce a feeling of early and prolonged fullness. It has collaboration with Mayo Clinic for the development and testing of products for the treatment of obesity. The company was formerly known as Beta Medical, Inc. and changed its name to EnteroMedics Inc. in 2003. EnteroMedics Inc. was founded in 2002 and is headquartered in St. Paul, Minnesota.

 

Trader Alert: Exelixis, Inc. (EXEL), EnteroMedics Inc. (ETRM), Denbury Resources Inc. (DNR)

Exelixis, Inc. (EXEL) grew with the stock adding 4.12% or $0.89 to close at $22.5 on active trading volume of 8.09M compared its three months average trading volume of 5.95M. The South San Francisco California 94080 based company operating under the Biotechnology industry has been trending up for the last 52 weeks, with the shares price now 431.91% up for the period and up by 50.91% so far this year. With price target of $20.5 and a 533.8% rebound from 52-week low, Exelixis, Inc. has plenty of upside potential, making it a hold with a view buy.

Exelixis, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of new medicines with the potential to enhance care and outcomes for people with cancer. It focuses on advancing cabozantinib, an inhibitor of multiple tyrosine kinases, including MET, AXL, and VEGF receptors, which has shown clinical anti-tumor activity in approximately 20 forms of cancer and is the subject of a broad clinical development program. The company has received regulatory approval for two separate formulations of cabozantinib for the treatment of certain forms of kidney and thyroid cancer and marketed as CABOMETYX tablets in the United States and COMETRIQ capsules in the United States and European Union respectively. It also offers COTELLIC (cobimetinib), a selective inhibitor of MEK, in the United States and European Union; and is being evaluated for further potential indications by Roche and Genentech under collaboration with Exelixis. Exelixis, Inc. has collaboration and license agreements with Ipsen Pharma SAS, Genentech, Inc., GlaxoSmithKline, Bristol-Myers Squibb Company, Sanofi, Merck, and Daiichi Sankyo Company Limited for the development and commercialization of various compounds and programs. The company was formerly known as Exelixis Pharmaceuticals, Inc. and changed its name to Exelixis, Inc. in February 2000. Exelixis, Inc. was founded in 1994 and is headquartered in South San Francisco, California.

EnteroMedics Inc. (ETRM) gained $1.03 to close the day at a new closing price of $8.15, a 14.47% increase in value from its previous closing price that moved the stock 20275% above its 52 week low of $0.04. A total of 7.96M shares exchanged hands during the day compared with its three month average trading volume of 12.38M. The stock, which fluctuated between $7.63 and $8.52 during the day, currently situated -73.2% below its 52 week high. The stock is down by -70.58% in the past one month and up by 13282.59% over the past three months. With a one year target estimate of $140 and RSI of 53.46, the stock still has upside potential, making it a hold for now.

EnteroMedics Inc., a medical device company, focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders. Its proprietary neuroblocking technology is designed to intermittently block the vagus nerve using electrical impulses. The company develops the Maestro Rechargeable System, which is used to limit the expansion of the stomach, control hunger sensations between meals, reduce the frequency and intensity of stomach contractions, and produce a feeling of early and prolonged fullness. It has collaboration with Mayo Clinic for the development and testing of products for the treatment of obesity. The company was formerly known as Beta Medical, Inc. and changed its name to EnteroMedics Inc. in 2003. EnteroMedics Inc. was founded in 2002 and is headquartered in St. Paul, Minnesota.

Denbury Resources Inc. (DNR) shares were up in last trading by 6.08% to $3.49. It experienced lighter than average volume on day. The stock increased in value by almost 2.65% over the past week and fell -5.42% in the past month. It is currently trading -5.73% below its 50 day moving average and 2.19% above its 200 day moving average. Following the recent increase in price, the stock’s new closing price represents a -27.29% decrease in value from its one year high of $4.8. The RSI indicator value of 44.9, lead us to believe that it is a hold for now.

Denbury Resources Inc. operates as an independent oil and natural gas company in the United States. The company primarily focuses on enhanced oil recovery utilizing carbon dioxide. It holds properties located in Mississippi, Texas, Louisiana, and Alabama in the Gulf Coast region; and in Montana, North Dakota, and Wyoming in the Rocky Mountain region. As of December 31, 2015, the company had 288.6 million barrels of oil equivalent of estimated proved oil and natural gas reserves. Denbury Resources Inc. was founded in 1951 and is headquartered in Plano, Texas.

 

Stocks in the Spotlight: Cooper Tire & Rubber Company (CTB), CBOE Holdings, Inc. (CBOE), EnteroMedics Inc. (ETRM)

Cooper Tire & Rubber Company (CTB) had a light trading with around 1.58M shares changing hands compared to its three month average trading volume of 518.38K. The stock traded between $34.58 and $36.15 before closing at the price of $34.7 with -3.61% change on the day. The Findlay Ohio 45840 based company is currently trading 19.16% above its 52 week low of $29.29 and -13.84% below its 52 week high of $40.75. Both the RSI indicator and target price of 36.77 and $43 respectively, lead us to believe that it should be put on hold over the coming weeks.

Cooper Tire & Rubber Company, together with its subsidiaries, manufactures and markets replacement tires worldwide. The company operates through Americas Tire Operations and International Tire Operations segments. It manufactures and markets passenger car, light truck, motorcycle, and racing tires, as well as tire retread material; and distributes tires for racing, medium trucks, and motorcycles. The company sells its products to independent tire dealers, wholesale distributors, regional and national retail tire chains, and other tire and automotive product retail chains, as well as original equipment manufacturers; and directly to end users through three owned retail stores. Cooper Tire & Rubber Company was founded in 1913 and is headquartered in Findlay, Ohio.

CBOE Holdings, Inc. (CBOE) managed to rebound with the stock climbing 1.8% or $1.4 to close the day at $79.19 on light trading volume of 1.57M shares, compared to its three month average trading volume of 827.49K. The Chicago Illinois 60605 based company has been outperforming the diversified investments group over the past 52 weeks, with the stock gaining 34.21%, compared to the industry which has advanced 27.39% over the same period. With RSI of 64.15, the stock should still continue to rise and get closer to its one year target estimate of $79.08, making it a hold for now.

CBOE Holdings, Inc., through its subsidiaries, operates as an options exchange and creator of listed options in the United States. It offers marketplaces for trading options on various market indexes; futures on the VIX Index; options on the stocks of individual corporations comprising equity options; and options on other exchange-traded products that include ETP options, such as exchange-traded funds and exchange-traded notes. The company owns and operates CBOE primary options market, which offers trading for listed options through a single system that integrates electronic trading and traditional open outcry trading on its trading floor in Chicago; CFE, an all-electronic futures exchange, which offers futures on the VIX Index, as well as on other products; and C2, an all-electronic exchange that also offers trading for listed options. Its exchanges operate on its proprietary technology platform, known as CBOE Command. The company has a strategic relationship with S&P OPCO LLC; Frank Russell Company; NASDAQ, Inc.; MSCI; and S&P Dow Jones Indices. CBOE Holdings, Inc. was founded in 1973 and is headquartered in Chicago, Illinois.

EnteroMedics Inc. (ETRM) shares were down in last trading by -3.93% to $7.34. It experienced lighter than average volume on day. The stock increased in value by almost 16.69% over the past week and fell -20.13% in the past month. It is currently trading 64.7% above its 50 day moving average and 449.48% above its 200 day moving average. Following the recent decrease in price, the stock’s new closing price represents a -75.86% decrease in value from its one year high of $30.41. The RSI indicator value of 50.93, lead us to believe that it is a hold for now.

EnteroMedics Inc., a medical device company, focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders. Its proprietary neuroblocking technology is designed to intermittently block the vagus nerve using electrical impulses. The company develops the Maestro Rechargeable System, which is used to limit the expansion of the stomach, control hunger sensations between meals, reduce the frequency and intensity of stomach contractions, and produce a feeling of early and prolonged fullness. It has collaboration with Mayo Clinic for the development and testing of products for the treatment of obesity. The company was formerly known as Beta Medical, Inc. and changed its name to EnteroMedics Inc. in 2003. EnteroMedics Inc. was founded in 2002 and is headquartered in St. Paul, Minnesota.

 

Trader’s Round Up: EnteroMedics Inc. (ETRM), Novavax, Inc. (NVAX), Ascena Retail Group, Inc. (ASNA)

EnteroMedics Inc. (ETRM) grew with the stock adding 1.33% or $0.1 to close at $7.64 on active trading volume of 2.73M compared its three months average trading volume of 12.5M. The St. Paul Minnesota 55113 based company operating under the Medical Appliances & Equipment industry has been trending up for the last 52 weeks, with the shares price now 594.55% up for the period and up by 282% so far this year. With price target of $140 and a 19000% rebound from 52-week low, EnteroMedics Inc. has plenty of upside potential, making it a hold with a view buy.

EnteroMedics Inc., a medical device company, focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders. Its proprietary neuroblocking technology is designed to intermittently block the vagus nerve using electrical impulses. The company develops the Maestro Rechargeable System, which is used to limit the expansion of the stomach, control hunger sensations between meals, reduce the frequency and intensity of stomach contractions, and produce a feeling of early and prolonged fullness. It has collaboration with Mayo Clinic for the development and testing of products for the treatment of obesity. The company was formerly known as Beta Medical, Inc. and changed its name to EnteroMedics Inc. in 2003. EnteroMedics Inc. was founded in 2002 and is headquartered in St. Paul, Minnesota.

Novavax, Inc. (NVAX) dropped $0 to close the day at a new closing price of $1.33, a 0% decrease in value from its previous closing price that moved the stock 14.66% above its 52 week low of $1.16. A total of 2.71M shares exchanged hands during the day compared with its three month average trading volume of 7.36M. The stock, which fluctuated between $1.3 and $1.35 during the day, currently situated -84.33% below its 52 week high. The stock is up by 0.76% in the past one month and up by 9.02% over the past three months. With a one year target estimate of $3.29 and RSI of 47.36, the stock still has upside potential, making it a hold for now.

Novavax, Inc., a clinical-stage vaccine company, focuses on discovering, developing, and commercializing recombinant nanoparticle vaccines and adjuvants. The company produces its vaccines using its proprietary recombinant nanoparticle vaccine technology. Its product pipeline includes respiratory syncytial virus (RSV) vaccine candidates for elderly and maternal immunization that are in Phase III clinical trials, as well as pediatric RSV candidate, which is in Phase I clinical trial; seasonal quadrivalent influenza and pandemic H7N9 vaccines, which are in Phase II clinical trials; vaccine candidate against Ebola Virus that is Phase I clinical trial, as well as combination respiratory vaccine candidate and seasonal influenza vaccine candidate that is in pre-clinical trial; and rabies G protein vaccine candidate, which is in Phase I/II clinical trial. The company also has pre-clinical stage programs for various infectious diseases, including the Middle East respiratory syndrome coronavirus; and develops technology for the production of immune stimulating saponin-based adjuvants. Novavax, Inc. was founded in 1987 and is headquartered in Gaithersburg, Maryland.

Ascena Retail Group, Inc. (ASNA) shares were down in last trading by -0.2% to $4.91. It experienced lighter than average volume on day. The stock increased in value by almost 6.51% over the past week and fell -18.71% in the past month. It is currently trading -20.07% below its 50 day moving average and -28.32% below its 200 day moving average. Following the recent decrease in price, the stock’s new closing price represents a -56.39% decrease in value from its one year high of $11.26. The RSI indicator value of 36.3, lead us to believe that it is a hold for now.

Ascena Retail Group, Inc., through its subsidiaries, operates as a specialty retailer of apparel, shoes, and accessories for women and tween girls in the United States, Canada, and Puerto Rico. The company operates through six segments: ANN, Justice, Lane Bryant, maurices, dressbarn, and Catherines. It creates, designs, and develops a range of merchandise, including apparel, accessories, footwear, and intimates; lifestyle products comprising cosmetics, bedroom furnishings, and electronics; and wear-to-work, casual sportswear, footwear, and social occasion apparel. The company also offers casual clothing, career wear, dressy apparel, and active wear, as well as special occasion and classic apparel. Its principal brands comprise ANN TAYLOR, LOFT, ANN TAYLOR LOFT, LOU & GREY, JUSTICE, LANE BRYANT, LANE BRYANT OUTLET, CACIQUE, RIGHT FIT, MAURICES, DRESSBARN, CATHERINES, CATHERINES PLUS SIZES, MAGGIE BARNES, LIZ&ME, SERENADA, DRESSBAR, 6th & LANE, and MAURICES IN MOTION. As of July 30, 2016, the company operated approximately 4,900 stores. It also offers its products through its Websites, including anntaylor.com, LOFT.com, louandgrey.com, shopjustice.com, lanebryant.com, cacique.com, maurices.com, dressbarn.com, and catherines.com. The company was formerly known as Dress Barn, Inc. and changed its name to Ascena Retail Group, Inc. in January 2011. Ascena Retail Group, Inc. was founded in 1962 and is based in Mahwah, New Jersey.

 

Stocks Under Review: The Manitowoc Company, Inc. (MTW), EnteroMedics Inc. (ETRM), Sanchez Energy Corporation (SN)

The Manitowoc Company, Inc. (MTW) failed to extend gains with the stock declining -8.31% or $-0.57 to close the day at $6.29 on active trading volume of 6.24M shares, compared to its three month average trading volume of 2.05M. The Manitowoc Wisconsin 54220 based company has been outperforming the farm & construction machinery group over the past 52 weeks, with the stock gaining 92.62%, compared to the industry which has advanced 53.33% over the same period. With RSI of 48.65, the stock should still continue to rise and get closer to its one year target estimate of $5.38, making it a hold for now.

The Manitowoc Company, Inc. designs, manufactures, and sells cranes and related products worldwide. It offers lattice-boom cranes, including crawler and truck mounted lattice-boom cranes, and crawler crane attachments; tower cranes comprising top slewing, luffing jib, topless, and self-erecting tower cranes; mobile telescopic cranes, including rough terrain, all-terrain, truck mounted, and industrial cranes; and boom trucks, such as telescopic boom trucks under the Manitowoc, Grove, Potain, National Crane, and Shuttlelift brands. The company also provides crane product parts and services; and crane rebuilding, remanufacturing, and training services under the Manitowoc Crane Care brand name. The company’s products are used in various applications, including energy and utilities; petrochemical and industrial projects; infrastructure development, such as road, bridge, and airport construction; and commercial and high-rise residential construction industries. The company was founded in 1853 and is based in Manitowoc, Wisconsin.

EnteroMedics Inc. (ETRM) retreated with the stock falling -14.08% or $-1.18 to close at $7.2 on active trading volume of 6.24M compared its three months average trading volume of 12.49M. The St. Paul Minnesota 55113 based company operating under the Medical Appliances & Equipment industry has been trending up for the last 52 weeks, with the shares price now 579.25% up for the period and up by 260% so far this year. With price target of $140 and a 17900% rebound from 52-week low, EnteroMedics Inc. has plenty of upside potential, making it a hold with a view buy.

EnteroMedics Inc., a medical device company, focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders. Its proprietary neuroblocking technology is designed to intermittently block the vagus nerve using electrical impulses. The company develops the Maestro Rechargeable System, which is used to limit the expansion of the stomach, control hunger sensations between meals, reduce the frequency and intensity of stomach contractions, and produce a feeling of early and prolonged fullness. It has collaboration with Mayo Clinic for the development and testing of products for the treatment of obesity. The company was formerly known as Beta Medical, Inc. and changed its name to EnteroMedics Inc. in 2003. EnteroMedics Inc. was founded in 2002 and is headquartered in St. Paul, Minnesota.

Sanchez Energy Corporation (SN) managed to rebound with the stock climbing 4.35% or $0.55 to close the day at $13.18 on higher than average trading volume of 6.16M shares, compared to its three month average trading volume of 3.39M. The Houston Texas 77002 based company has been outperforming the independent oil & gas companies by 109.1315% for last three months and its recent gains have pushed the stock slightly up 45.96% YTD, versus the independent oil & gas industry which is down -2.5% for the same period. The RSI of 62.77 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

Sanchez Energy Corporation, an independent exploration and production company, engages in the exploration, acquisition, and development of oil and natural gas resources in the onshore U.S. Gulf Coast. It holds a 93% working interest in the Eagle Ford Shale, which consists of approximately 200,000 net leasehold acres in the oil and condensate, or black oil and volatile oil located in South Texas; and a 65% working interest in the Tuscaloosa Marine Shale covering an area of approximately 62,000 net leasehold acres situated in Mississippi and Louisiana. The company was founded in 2011 and is headquartered in Houston, Texas.

 

Stocks Buzz: EnteroMedics Inc. (ETRM), Brookdale Senior Living Inc. (BKD), WPX Energy, Inc. (WPX)

EnteroMedics Inc. (ETRM) managed to rebound with the stock climbing 33.23% or $2.09 to close the day at $8.38 on light trading volume of 10.26M shares, compared to its three month average trading volume of 12.41M. The St. Paul Minnesota 55113 based company has been outperforming the medical appliances & equipment group over the past 52 weeks, with the stock gaining 874.42%, compared to the industry which has advanced 15.74% over the same period. With RSI of 53.67, the stock should still continue to rise and get closer to its one year target estimate of $140, making it a hold for now.

EnteroMedics Inc., a medical device company, focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders. Its proprietary neuroblocking technology is designed to intermittently block the vagus nerve using electrical impulses. The company develops the Maestro Rechargeable System, which is used to limit the expansion of the stomach, control hunger sensations between meals, reduce the frequency and intensity of stomach contractions, and produce a feeling of early and prolonged fullness. It has collaboration with Mayo Clinic for the development and testing of products for the treatment of obesity. The company was formerly known as Beta Medical, Inc. and changed its name to EnteroMedics Inc. in 2003. EnteroMedics Inc. was founded in 2002 and is headquartered in St. Paul, Minnesota.

Brookdale Senior Living Inc. (BKD) grew with the stock adding 0.6% or $0.09 to close at $15.06 on light trading volume of 10.11M compared its three months average trading volume of 4.73M. The Brentwood Tennessee 37027 based company operating under the Long-Term Care Facilities industry has been trending down for the last 52 weeks, with the shares price now -4.14% down for the period and up by 21.26% so far this year. With price target of $16.29 and a 41.41% rebound from 52-week low, Brookdale Senior Living Inc. has plenty of upside potential, making it a hold with a view buy.

Brookdale Senior Living Inc. owns and operates senior living communities in the United States. It operates through five segments: Retirement Centers, Assisted Living, Continuing Care Retirement Centers (CCRCs) – Rental, Brookdale Ancillary Services, and Management Services. The Retirement Centers segment owns or leases communities comprising independent living and assisted living units in a single community that are primarily designed for middle to upper income senior citizens. The Assisted Living segment owns or leases communities consisting of freestanding, multi-story communities, and freestanding single story communities, which offer housing and 24-hour assistance with activities of daily life to mid-acuity frail and elderly residents. This segment also operates memory care communities for residents with Alzheimer’s disease and other dementias. The CCRCs – Rental segment owns or leases communities that offer various living arrangements and services to accommodate various levels of physical ability and health. The Brookdale Ancillary Services segment provides outpatient therapy, home health, and hospice services to residents of its communities, as well as to other senior living communities. The Management Services segment operates communities under the management agreements. As of December 31, 2015, the company operated 130 retirement center communities with 24,486 units; 915 assisted living communities with 62,567 units; and 78 CCRCs with 21,367 units, as well as owned or leased 959 communities with 81,067 units and provided management services with respect to 164 communities with 27,353 units for third parties or unconsolidated ventures. Brookdale Senior Living Inc. is headquartered in Brentwood, Tennessee.

WPX Energy, Inc. (WPX) continued its downward trend with the stock declining -0.29% or $-0.04 to close the day at $13.89 on lower than average trading volume of 10.04M shares, compared to its three month average trading volume of 8.4M. The Tulsa Oklahoma 74172 based company has been outperforming the independent oil & gas companies by 27.8347% for last three months and its recent gains have offset losses to -4.67% YTD, versus the independent oil & gas industry which is down -3.25% for the same period. The RSI of 43.87 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

WPX Energy, Inc., an independent oil and natural gas exploration and production company, engages in the exploitation and development of unconventional properties in the United States. Its principal areas of operation include the Permian Basin in Texas and New Mexico, the Williston Basin in North Dakota, and the San Juan Basin in New Mexico and Colorado. As of December 31, 2014, the company had proved reserves of 583 million barrels of oil equivalent. WPX Energy, Inc. was incorporated in 2011 and is headquartered in Tulsa, Oklahoma.

 

Stock’s Trend Analysis Report: Headwaters Incorporated (HW), Ocular Therapeutix, Inc. (OCUL), EnteroMedics Inc. (ETRM)

Headwaters Incorporated (HW) climbed 0.09% during last trading as the stock added $0.02 to finish the day at $23.21 with about 1.31M shares changing hands, compared to its three month average trading volume of 1.5M. The $1.72B market cap company, which fluctuated between $23.15 and $23.23 during the day, currently situated 62.76% above its 52 week low of $14.86 and -3.25% away from its one year high of $23.99. The RSI of 36.58 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

Headwaters Incorporated, a building materials company, provides products and services to building and construction materials sectors primarily in the United States and Canada. It operates through three segments: Building Products, Construction Materials, and Energy Technology. The Building Products segment designs, manufactures, and markets siding and exterior siding accessories, including decorative window shutters, gable vents, mounting blocks for exterior fixtures, roof ventilation, trim board and molding products, specialty siding products, and window well systems; professional tools, such as portable cutting and shaping tools; manufactured architectural stone products; resin-based composite, concrete, and stone-coated metal roofing products; vinyl windows; decking related products; and concrete-based masonry products comprising standard grey blocks, split and ground face blocks, and polished and textured blocks. This segment sells its products under the Eldorado Stone, Dutch Quality Stone, StoneCraft, InSpire, Aledora, Enviroshake, Entegra, Gerard, Allmet, and Metrotile brand names. This segment distributes its products through a network of distributors, such as masonry and stone suppliers, roofing and siding material distributors, fireplace suppliers, and other contractor specialty stores, as well as through national and regional retail home centers and direct sales. The Construction Materials segment manages and markets coal combustion products (CCP), including fly ash that is used as a replacement for Portland cement in various concrete applications, such as infrastructure, commercial, and residential construction; process and markets synthetic gypsum; and provides CCP disposal services, as well as services to electric utilities related to the management of CCPs. The Energy Technology segment develops and commercializes HCAT, a heavy oil upgrading technology. Headwaters Incorporated was founded in 1987 and is headquartered in South Jordan, Utah.

Ocular Therapeutix, Inc. (OCUL) dropped $-0.43 to close the day at a new closing price of $6.44, a -6.26% decrease in value from its previous closing price that moved the stock 59.41% above its 52 week low of $4.04. A total of 1.31M shares exchanged hands during the day compared with its three month average trading volume of 972.64K. The stock, which fluctuated between $6.27 and $6.75 during the day, currently situated -55.59% below its 52 week high. The stock is down by -21.27% in the past one month and up by 5.23% over the past three months. With a one year target estimate of $28.4 and RSI of 25.45, the stock still has upside potential, making it a buy for now.

Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies for diseases and conditions of the eye using its proprietary hydrogel platform technology in the United States. It markets ReSure Sealant, a hydrogel-based ophthalmic wound sealant to seal corneal incisions following cataract surgery. The company’s lead product includes DEXTENZA, which is in Phase III clinical trial for the treatment of post-surgical ocular inflammation and pain during cataract surgery, as well as for the treatment of allergic conjunctivitis; and in Phase II clinical trial for the treatment of inflammatory dry eye disease. It is also developing OTX-TP, which has completed Phase IIb clinical trial for glaucoma and ocular hypertension. In addition, the company has a pipeline of earlier stage punctum plug product candidates, including OTX-MP, which has completed a Phase I clinical trial evaluating safety and pharmacokinetics in patients during cataract surgery; and evaluates sustained-release injectable anti-VEGF drug depots for back-of-the-eye diseases. It has a strategic collaboration, option, and license agreement with Regeneron Pharmaceuticals, Inc. for the development of sustained release formulation of the vascular endothelial growth factor trap aflibercept for the treatment of wet age-related macular degeneration and other serious retinal diseases. Ocular Therapeutix, Inc. was founded in 2006 and is headquartered in Bedford, Massachusetts.

EnteroMedics Inc. (ETRM) had a light trading with around 1.31M shares changing hands compared to its three month average trading volume of 12.44M. The stock traded between $6.25 and $6.97 before closing at the price of $6.52 with -6.32% change on the day. The St. Paul Minnesota 55113 based company is currently trading 16200% above its 52 week low of $0.04 and -78.56% below its 52 week high of $30.41. Both the RSI indicator and target price of 49.29 and $140 respectively, lead us to believe that it should be put on hold over the coming weeks.

EnteroMedics Inc., a medical device company, focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders. Its proprietary neuroblocking technology is designed to intermittently block the vagus nerve using electrical impulses. The company develops the Maestro Rechargeable System, which is used to limit the expansion of the stomach, control hunger sensations between meals, reduce the frequency and intensity of stomach contractions, and produce a feeling of early and prolonged fullness. It has collaboration with Mayo Clinic for the development and testing of products for the treatment of obesity. The company was formerly known as Beta Medical, Inc. and changed its name to EnteroMedics Inc. in 2003. EnteroMedics Inc. was founded in 2002 and is headquartered in St. Paul, Minnesota.

 

Trader Alert: Wabash National Corporation (WNC), EnteroMedics Inc. (ETRM), InvenSense, Inc. (INVN)

Wabash National Corporation (WNC) grew with the stock adding 1.92% or $0.34 to close at $18.01 on active trading volume of 1.39M compared its three months average trading volume of 1.37M. The Lafayette Indiana 47905 based company operating under the Trucks & Other Vehicles industry has been trending up for the last 52 weeks, with the shares price now 71.69% up for the period and up by 14.28% so far this year. With price target of $14.31 and a 75.69% rebound from 52-week low, Wabash National Corporation has plenty of upside potential, making it a hold with a view buy.

Wabash National Corporation designs, manufactures, and markets truck and tank trailers, intermodal equipment, and transportation related products in North America. Its Commercial Trailer Products segment provides dry van trailers; platform trailers; refrigerated trailers; specialty products, such as converter dollies, big tire haulers, steel coil haulers, and roadrailer trailers; aftermarket parts and rail components; truck bodies; used trailers; and laminated hard wood oak products. The company’s Diversified Products segment offers transportation products, including stainless steel and aluminum liquid and dry bulk tank trailers and other liquid transport solutions for the dairy, food and beverage, chemical, environmental, petroleum, and refined fuel industries; aircraft refuelers and hydrant dispensers for in-to-plane fueling companies, airlines, freight distribution companies, and fuel marketers; military grade refueling and water tankers; truck mounted tanks for fuel delivery; and vacuum tankers. This segment also provides engineered products comprising products for storage, mixing, and blending, including process vessels, as well as round horizontal and vertical storage silo tanks; containment and isolation systems for the pharmaceutical, chemical, and nuclear industries; containment systems for the pharmaceutical, chemical, and biotech markets; and mobile water storage tanks used in the oil and gas industry. The Retail segment operates 15 owned retail branch locations, which sell new and used trailers, aftermarket parts, and services. The company offers its products under the Wabash, Wabash National, DuraPlate, DuraPlate HD, DuraPlate XD-35, DuraPlate AeroSkirt, ArcticLite, RoadRailer, TrustLock Plus, Transcraft, Benson, Walker Transport, Walker Engineered Products, Brenner Tank, Garsite, Progress Tank, Bulk Tank International, Extract Technology, and Beall brand names. Wabash National Corporation was founded in 1985 and is headquartered in Lafayette, Indiana.

EnteroMedics Inc. (ETRM) dropped $-0.01 to close the day at a new closing price of $7.33, a -0.14% decrease in value from its previous closing price that moved the stock 18225% above its 52 week low of $0.04. A total of 1.39M shares exchanged hands during the day compared with its three month average trading volume of 12.47M. The stock, which fluctuated between $7.01 and $7.48 during the day, currently situated -75.9% below its 52 week high. The stock is up by 16009.89% in the past one month and up by 7230% over the past three months. With a one year target estimate of $140 and RSI of 51.06, the stock still has upside potential, making it a hold for now.

EnteroMedics Inc., a medical device company, focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders. Its proprietary neuroblocking technology is designed to intermittently block the vagus nerve using electrical impulses. The company develops the Maestro Rechargeable System, which is used to limit the expansion of the stomach, control hunger sensations between meals, reduce the frequency and intensity of stomach contractions, and produce a feeling of early and prolonged fullness. It has collaboration with Mayo Clinic for the development and testing of products for the treatment of obesity. The company was formerly known as Beta Medical, Inc. and changed its name to EnteroMedics Inc. in 2003. EnteroMedics Inc. was founded in 2002 and is headquartered in St. Paul, Minnesota.

InvenSense, Inc. (INVN) shares were up in last trading by 0.71% to $12.73. It experienced lighter than average volume on day. The stock decreased in value by almost 0% over the past week and fell -1.09% in the past month. It is currently trading 20.26% above its 50 day moving average and 61.1% above its 200 day moving average. Following the recent increase in price, the stock’s new closing price represents a -1.47% decrease in value from its one year high of $12.92. The RSI indicator value of 72.31, lead us to believe that it may reverse gains in the near term.

InvenSense, Inc. designs, develops, manufactures, markets, and sells sensor systems on a chip in the United States, China, Taiwan, South Korea, Japan, France, Canada, Slovakia, and Italy. It offers accelerometers, gyroscopes, and microphones for the mobile, wearable, smart home, gaming, industrial, and automotive market segments. The company delivers solutions based on motion and sound technology to smartphones, tablets, wearables, console and portable video gaming devices, digital television and set-top box remote controls, fitness accessories, sports equipment, digital still cameras, automobiles, ultra-books, laptops, hearing aids, stabilization systems, tools, navigation devices, remote controlled toys, and other household consumer and industrial devices. It also provides sensor data analytics platforms and services. The company sells its products to consumer electronics device manufacturers, original design manufacturers, and contract manufacturers directly, as well as through distributors. InvenSense, Inc. has a collaboration with Panasonic Corporation for the development of sensor technology solutions and automotive safety micro electrical mechanical systems based inertial sensors. The company was founded in 2003 and is headquartered in San Jose, California.

 

Stocks on the Move: EnteroMedics Inc. (ETRM), The AES Corporation (AES), Delta Air Lines, Inc. (DAL)

EnteroMedics Inc. (ETRM) failed to extend gains with the stock declining -2.64% or $-0.21 to close the day at $7.75 on active trading volume of 8.85M shares, compared to its three month average trading volume of 12.39M. The St. Paul Minnesota 55113 based company has been outperforming the medical appliances & equipment group over the past 52 weeks, with the stock gaining 487.12%, compared to the industry which has advanced 11.45% over the same period. With RSI of 51.82, the stock should still continue to rise and get closer to its one year target estimate of $140, making it a hold for now.

EnteroMedics Inc., a medical device company, focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders. Its proprietary neuroblocking technology is designed to intermittently block the vagus nerve using electrical impulses. The company develops the Maestro Rechargeable System, which is used to limit the expansion of the stomach, control hunger sensations between meals, reduce the frequency and intensity of stomach contractions, and produce a feeling of early and prolonged fullness. It has collaboration with Mayo Clinic for the development and testing of products for the treatment of obesity. The company was formerly known as Beta Medical, Inc. and changed its name to EnteroMedics Inc. in 2003. EnteroMedics Inc. was founded in 2002 and is headquartered in St. Paul, Minnesota.

The AES Corporation (AES) fell -1.67% during last trading as the stock lost $-0.19 to finish the day at $11.22 with about 8.79M shares changing hands, compared to its three month average trading volume of 5.21M. The $7.6B market cap company, which fluctuated between $11.19 and $11.46 during the day, currently situated 35.96% above its 52 week low of $8.77 and -14.97% away from its one year high of $13.32. The RSI of 41.19 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

The AES Corporation operates as a diversified power generation and utility company. It owns and/or operates power plants to generate and sell power to customers, such as utilities, industrial users, and other intermediaries. The company also owns and/or operates utilities to generate or purchase, distribute, transmit, and sell electricity to end-user customers in the residential, commercial, industrial, and governmental sectors; and generates and sells electricity on the wholesale market. It uses a range of fuels to generate electricity, including natural gas, coal, hydro, wind, energy storage, oil, diesel, petroleum coke, biomass, landfill gas, and solar. The company owns and/or operates a generation portfolio of approximately 29,352 megawatts. It has operations in the United States, Chile, Colombia, Argentina, Brazil, Mexico, Central America, the Caribbean, Europe, and Asia. The company was formerly known as Applied Energy Services, Inc. and changed its name to The AES Corporation in April 2000. The AES Corporation was founded in 1981 and is headquartered in Arlington, Virginia.

Delta Air Lines, Inc. (DAL) saw its value decrease by -3.43% as the stock dropped $-1.73 to finish the day at a closing price of $48.77. The stock was higher in trading and has fluctuated between $32.6-$52.76 per share for the past year. The shares, which traded within a range of $48.77 to $50.43 during the day, are up by 18.17% in the past three months and up by 26.45% over the past six months. It is currently trading -2.81% below its 20 day moving average and -1.1% below its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $0 a share over the next twelve months. The current relative strength index (RSI) reading is 42.75. The technical indicator lead us to believe there will be no major movement any time soon, hold.

Delta Air Lines, Inc. provides scheduled air transportation for passengers and cargo in the United States and internationally. The company operates through two segments, Airline and Refinery. Its route network is centered around a system of hubs, international gateways, and airports in Amsterdam, Atlanta, Boston, Detroit, London-Heathrow, Los Angeles, Minneapolis-St. Paul, New York-LaGuardia, New York-JFK, Paris-Charles de Gaulle, Salt Lake City, Seattle, and Tokyo-Narita. The company sells its tickets through various distribution channels, including delta.com and mobile, telephone reservations, traditional brick and mortar, and online travel agencies. It also provides aircraft maintenance, repair, and overhaul services; staffing, and professional security and training services, as well as aviation solutions to third parties; vacation packages to third-party consumers; and aircraft charters, and aircraft management and programs. As of February 3, 2016, the company operated a fleet of approximately 800 aircrafts. Delta Air Lines, Inc. was founded in 1924 and is headquartered in Atlanta, Georgia.